CompilationStudy shows effectiveness of adjuvanted vaccine RSVPreF3 OA respiratory syncytial virus (RSV) in people over 60 years of age and…
GSK has launched the Efficacy of Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine in Adults in Spain study1, which aims to…
Compilation. A GSK-sponsored survey of 3,500 adults over 50 in 12 countries estimated knowledge participants about the risk and severity…